Literature DB >> 32925503

Primary presentation of COVID-19 solely with gastrointestinal symptoms: a problem for the containment of the disease.

Christoph G Dietrich1, Dolores Hübner2, Gernot Marx3, Johannes Bickenbach3, Andreas Bootsveld1.   

Abstract

An oligosymptomatic patient with initially exclusively gastrointestinal symptoms (massive nausea and mild pancreatitis) turned out to suffer from COVID-19 during the hospital stay. The patient did not exhibit the typical COVID-symptoms cough or fever despite lung involvement. The gastroenterological diagnostic investigations comprised abdominal ultrasound, gastroscopy and endoscopic ultrasound and first revealed no clear cause of these symptoms. In an abdominal computed tomography (CT) scan, patchy ground-glass opacities in both lungs were discovered and the following chest CT scan and a virus PCR test revealed the right and surprising diagnosis. This case report depicts the clinical course of this atypical case and discusses gastrointestinal COVID-manifestations and clinical consequences as well as consequences of this atypical presentation for disease control.

Entities:  

Mesh:

Year:  2020        PMID: 32925503     DOI: 10.1097/MEG.0000000000001922

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  10 in total

Review 1.  Review on acute pancreatitis attributed to COVID-19 infection.

Authors:  Takumi Onoyama; Hiroki Koda; Wataru Hamamoto; Shiho Kawahara; Yuri Sakamoto; Taro Yamashita; Hiroki Kurumi; Soichiro Kawata; Yohei Takeda; Kazuya Matsumoto; Hajime Isomoto
Journal:  World J Gastroenterol       Date:  2022-05-21       Impact factor: 5.374

2.  Are asymptomatic gastrointestinal findings on imaging more common in COVID-19 infection? Study to determine frequency of abdominal findings of COVID-19 infection in patients with and without abdominal symptoms and in patients with chest-only CT scans.

Authors:  Sree Harsha Tirumani; Ata A Rahnemai-Azar; Jonathan D Pierce; Keval D Parikh; Sooyoung S Martin; Robert Gilkeson; Nikhil H Ramaiya
Journal:  Abdom Radiol (NY)       Date:  2021-01-04

Review 3.  Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis.

Authors:  Mohammad Shehab; Fatema Alrashed; Sameera Shuaibi; Dhuha Alajmi; Alan Barkun
Journal:  BMJ Open Gastroenterol       Date:  2021-03

Review 4.  Acute pancreatitis and COVID-19: a new target for infection?

Authors:  Júlia Aith Balthazar; Ethel Zimberg Chehter
Journal:  Einstein (Sao Paulo)       Date:  2022-02-21

5.  A Microbiome-Driven Approach to Combating Depression During the COVID-19 Pandemic.

Authors:  Mahmoud A Ghannoum; MaryKate Ford; Robert A Bonomo; Ahmed Gamal; Thomas S McCormick
Journal:  Front Nutr       Date:  2021-08-24

Review 6.  Systematic review and meta-analysis of clinical outcomes of COVID-19 patients undergoing gastrointestinal endoscopy.

Authors:  Xiangzhou Tan; Jianping Guo; Zihua Chen; Alfred Königsrainer; Dörte Wichmann
Journal:  Therap Adv Gastroenterol       Date:  2021-08-30       Impact factor: 4.409

7.  Association between gastrointestinal symptoms and disease severity in patients with COVID-19 in Tehran City, Iran.

Authors:  Elena Lak; Seyed Amir Sheikholeslami; Mahmoud Dehghani Ghorbi; Mostafa Shafei; Homayon Yosefi
Journal:  Prz Gastroenterol       Date:  2021-05-18

Review 8.  Extrapulmonary onset manifestations of COVID-19.

Authors:  Josef Finsterer; Fulvio A Scorza; Carla A Scorza; Ana C Fiorini
Journal:  Clinics (Sao Paulo)       Date:  2021-07-05       Impact factor: 2.365

9.  Novel Coronavirus (COVID-19) Infection-Attributed Acute Pancreatitis: A Case Report and Literature Review.

Authors:  Rohit Chandra; Nicholas J Lazar; Seth Goldman; Zaid Imam; Ramy Mansour
Journal:  Cureus       Date:  2021-06-17

Review 10.  Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination.

Authors:  Shinya Yamada; Hidesaku Asakura
Journal:  Int J Mol Sci       Date:  2022-03-19       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.